postmenopozal dönemdeki kadınlara uygulanan hormon tedavisi ve ...

72) Mohr JA, Rogers J. Stres urinary incontinence: A simple and practicle approach to diagnosis and
treatment. J Am Geriatr Soc. 1992; (31) : 476.
73) Fantl JA, Wyman JF. Postmenopusal urinary incontinence: comparison between non-estrogen
supplemented and estrogen-supplemented women. Obstet Gynecol. 1990; (71) : 823.
74) Bhattia NN, Bergman A. Effect of estrogen on urethral function in women with stres inkontinence.
Obstet Gynecol. 1989; (160) :176.
75) Bergman A, Karam MM. Changesin urethral cytology following estrogen administration. Gynecol
Obstet nvest. 1990; (29) :211.
76) Samsioe G. Occurrence,nature and treatment of urinary incontinence in a 70-year old female population.
Maturitas. 2000; (7) :335.
77) Cardoza LD. Estriol in the treatment of postmenopausal urgency Maturitas. 1993; (180) :47.
78) osif CS. Effects of protracted administration of estriol on the lower urinary tract in postmenopausal
women. Arch Gynecol Obstet. 1992; (251) :115.
79) Kerhsen RT. Comporising stady between Oxybutin Tolderodine and Trospium Clorid. Current Urology
Reports. 2004; (5) :359-367.
80) Erikson PS, Rasmussen H. Low dose 17 beta estradiol vaginal tablets in the treatment of atrophic
vaginitis a double-blind placebo controlled study. Eur. J Obstet Gynecol Reprod Biol. 1992; (440) :137.
81) Sartori MG. Menopausal genuine stres urinary incontinence treated with conjugated estrogens plus
progestogens. nt J Gynecol Obstet. 1995; (49) :165.
82) Fantl JA. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gynecol.
1996; (88) :745.
83) Kjaergaard B. Treatment with low dose vaginal estradiol in postmenopausal women. Ugeskr Laeger.
1990; (152) :6358.
84) Kirkengen AL. Ostriol in the prophylactic treatment of recurrent urinary tract infections in
postmenopausal women. Scand J Prim Health Care. 1992; (10) :139.
85) Raz S. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract
infctions. N Eng J Med. 1993; (329) :753.
86) Grodstein F, Lifford K. Postmenopausal Hormone Therapy and Risk of Developing Urinary
ncontinence. Am.College of Obstetricians and Gynecologist. 2004; (103/2) :254-260.
87) Grady D, Brown J. Postmenopausal Hormones and ncontinence:The Heart and Estrogen/Progestin
Replacement Study. Obstetrics end Gynecology. 2001; (97/1) :116-120.
88) Samuelsson EG, Victor ET, Svardsudd KF. Five-yar incidence and remission rates of female urinary
incontinence in a Swedish population less then 65 years old. Am.J Obstet Gynecol. 2001; (183) :568-574.
89) Goldstein SR, Nanavati N. Adverse events that are associated with the selective estrogen receptor
modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol. 2002;
81